Figure 3From: Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF)Univariate analysis found no differences in overall survival (OS) between patients, with and without GATA-1 (3a), GATA-2 (3b), EKLF (3c) and cMPL (3d) mRNA expression. Patients expressing EKLF had longer OS than those patients not expressing EKLF (median OS was 35.61 months and 19.31 months, respectively, P = 0.0241). GATA binding protein 1 (GATA1), GATA binding protein 2 (GATA2), Erythroid Krüppel-like Factor (EKLF) and Mieloproliferative Leukemia virus oncogen homology (c-MPL).Back to article page